Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03498716
Brief Title: A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer (IMpassion030)

First Submitted : February 28, 2018
First Submitted that Met QC Criteria : April 12, 2018
First Posted : April 17, 2018

Last Update Submitted that Met QC Criteria : January 6, 2020
Last Update Posted : January 9, 2020